OC
EOLS icon

Oppenheimer & Co’s Evolus EOLS Stock Holding History

Oppenheimer & Co’s Portfolio EOLS Stock Details EOLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-13,113
Closed -$212K – 1580
2024
Q3 		$212K Buy
+13,113
New +$183K ﹤0.01% 1382

Other funds holding EOLS

PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
CP
Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

Oppenheimer & Co's EOLS Position: Q4 2024 in Review

Oppenheimer & Co sold out of Evolus (EOLS) in Q4 2024, closing a stake of 13,113 shares — an estimated $212K sold.

Oppenheimer & Co first reported a position in EOLS in Q3 2024 and held it in 1 quarter. The position peaked at $212K in Q3 2024. 164 funds tracked by Wall St. Rank hold EOLS as of Q4 2024.

  • Oppenheimer & Co reported no remaining Evolus position as of Q4 2024 after selling out during the quarter.
  • Oppenheimer & Co sold 13,113 Evolus shares in Q4 2024, an estimated $212K.
  • Oppenheimer & Co first reported a position in Evolus in Q3 2024 and held it in 1 quarter.
  • Oppenheimer & Co's Evolus position peaked at $212K in Q3 2024.
  • 164 funds tracked by Wall St. Rank held Evolus as of Q4 2024.

Based on Oppenheimer & Co's 13F filing for Q4 2024, filed 5 Feb 2025.